Elixiron Immunotherapeutics Awarded Alzheimer's Association Grant to Target Microglia in Alzheimer's Disease

TAIPEI, Taiwan, Aug. 25, 2020 /PRNewswire/ -- Elixiron Immunotherapeutics Inc. today announced that it has been awarded a $1,000,000 grant from the Alzheimer's Association under the 2020 Part the Cloud-Bill Gates Partnership Grant Program to support a U.S. FDA-approved first-in-human...

from PR Newswire: https://ift.tt/34yhgFs